Form 8-K - Current report:
SEC Accession No. 0001104659-26-059409
Filing Date
2026-05-12
Accepted
2026-05-12 16:15:55
Documents
11
Period of Report
2026-05-07
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2614062d1_8k.htm   iXBRL 8-K 27090
  Complete submission text file 0001104659-26-059409.txt   192573

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA bzyr-20260507.xsd EX-101.SCH 3041
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE bzyr-20260507_lab.xml EX-101.LAB 34239
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bzyr-20260507_pre.xml EX-101.PRE 22376
15 EXTRACTED XBRL INSTANCE DOCUMENT tm2614062d1_8k_htm.xml XML 3185
Mailing Address 9432 KATY FREEWAY HOUSTON TX 77055
Business Address 12000 RICHMOND AVE HOUSTON TX 77082 (713) 335-5697
BURZYNSKI RESEARCH INSTITUTE INC (Filer) CIK: 0000724445 (see all company filings)

EIN.: 760136810 | State of Incorp.: DE | Fiscal Year End: 0228
Type: 8-K | Act: 34 | File No.: 000-23425 | Film No.: 26968775
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)